Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Development of Fecal Microbial Enzyme Mix for Mutagenicity Assay of Natural Products

  • Yeo, Hee-Kyung (Department of Food and Nutrition, Kyung Hee University) ;
  • Hyun, Yang-Jin (Department of Life and Nanopharmaceutical Sciences and Department of Pharmacy, Kyung Hee University) ;
  • Jang, Se-Eun (Department of Food and Nutrition, Kyung Hee University) ;
  • Han, Myung-Joo (Department of Food and Nutrition, Kyung Hee University) ;
  • Lee, Yong-Sup (Department of Life and Nanopharmaceutical Sciences and Department of Pharmacy, Kyung Hee University) ;
  • Kim, Dong-Hyun (Department of Life and Nanopharmaceutical Sciences and Department of Pharmacy, Kyung Hee University)
  • Received : 2011.12.15
  • Accepted : 2012.01.27
  • Published : 2012.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

Orally administered herbal glycosides are metabolized to their hydrophobic compounds by intestinal microflora in the intestine of animals and human, not liver enzymes, and absorbed from the intestine to the blood. Of these metabolites, some, such as quercetin and kaempherol, are mutagenic. The fecal bacterial enzyme fraction (fecalase) of human or animals has been used for measuring the mutagenicity of dietary glycosides. However, the fecalase activity between individuals is significantly different and its preparation is laborious and odious. Therefore, we developed a fecal microbial enzyme mix (FM) usable in the Ames test to remediate the fluctuated reaction system activating natural glycosides to mutagens. We selected, cultured, and mixed 4 bacteria highly producing glycosidase activities based on a cell-free extract of feces (fecalase) from 100 healthy Korean volunteers. When the mutagenicities of rutin and methanol extract of the flos of Sophora japonica L. (SFME), of which the major constituent is rutin, towards Salmonella typhimurium strains TA 98, 100, 102, 1,535, and 1,537 were tested using FM and/or S9 mix, these agents were potently mutagenic. These mutagenicities using FM were not significantly different compared with those using Korean fecalase. SFME and rutin were potently mutagenic in the test when these were treated with fecalase or FM in the presence of S9 mix, followed by those treated with S9 mix alone and those with fecalase or FM. Freeze-dried FM was more stable in storage than fecalase. Based on these findings, FM could be usable instead of human fecalase in the Ames test.

Keywords

References

  1. Akao, T., H. Kida, M. Kanaoka, M. Hattori, and K. Kobashi. 1988. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50: 1155-1160.
  2. Akao, T., M. Kanaoka, and K. Kobashi. 1988. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration - measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21: 245-249.
  3. Ames, B. N., J. McCann, and E. Tamasaki. 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31: 347-364. https://doi.org/10.1016/0165-1161(75)90046-1
  4. Ames, B. N. 1979. Identifying environmental chemicals causing mutations and cancer. Science 204: 587-593. https://doi.org/10.1126/science.373122
  5. Bae, E. A., M. K. Choo, E. K. Park, S. Y. Park, H. Y. Shin, and D. H. Kim. 2002. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol. Pharm. Bull. 25: 743-747. https://doi.org/10.1248/bpb.25.743
  6. Boyle, S. P., V. L. Dobson, S. J. Duthie, D. C. Hinselwood, J. A. Kyle, and A. R. Collins. 2000. Bioavailability and efficiency of rutin as an antioxidant: A human supplementation study. Eur. J. Clin. Nutr. 54: 774-782. https://doi.org/10.1038/sj.ejcn.1601090
  7. Brown, J. P. and P. S. Dietrich. 1979. Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: Activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutat. Res. 66: 223-240. https://doi.org/10.1016/0165-1218(79)90083-1
  8. Choi, J. R., S. W. Hong, Y. Kim, S. E. Jang, N. J. Kim, and D. H. Kim. 2011. Metabolic activities of ginseng and its constituents, ginsenoside Rb1 and Rg1, by human intestinal microflora. J. Ginseng Res. 35: 301-307. https://doi.org/10.5142/jgr.2011.35.3.301
  9. Choo, M. K., E. K. Park, M. J. Han, and D. J. Kim. 2003. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Planta Med. 69: 518-522. https://doi.org/10.1055/s-2003-40653
  10. Dunnick, J. K. and J. R. Hailey. 1992. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam. Appl. Toxicol. 19: 423-431. https://doi.org/10.1016/0272-0590(92)90181-G
  11. Ikeda, N., Y. Saito, J. Shimazu, A. Ochi, J. Mizutani, and J. Watanabe. 1994. Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults. J. Appl. Bacteriol. 77: 185-194. https://doi.org/10.1111/j.1365-2672.1994.tb03063.x
  12. Kim, D. H., E. A. Jung, I. S. Sohng, J. A. Han, T. H. Kim, and M. J. Han. 1998. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 21: 17-23. https://doi.org/10.1007/BF03216747
  13. Kim, D. H. 2002. Intestinal microflora activate the pharmacological effects of herbal medicines. Nat. Prod. Sci. 8: 35-43.
  14. Kobashi, K. and T. Akao. 1997. Relation of intestinal bacteria to pharmacological effect of glycosides. Biosci Microflora 16: 1-7.
  15. Kobashi, K., H. Nakata, H. Takebe, and K. Terasawa. 1984. Relation of intestinal microflora to Syo. Wakan-iyaku-kaishi 1: 166-167.
  16. Laqueur, G. L. 1964. Carcinogenic effects of cycad meal and cycasin, methylazoxymethanol glycoside, in rats and effects of cycasin in germ-free rats. Fed. Proc. 23: 1386-1388.
  17. Lee, D. S., Y. S. Kim, C. N. Ko, K. H. Cho, H. S. Bae, K. S. Lee, et al. 2002. Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res. 25: 165-169. https://doi.org/10.1007/BF02976558
  18. Lee, J., E. Lee, D. Kim, J. Lee, J. Yoo, and B. Koh. 2009. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J. Ethnopharmacol. 122: 143-148. https://doi.org/10.1016/j.jep.2008.12.012
  19. MacGregor, J. T. and L. Jurd. 1978. Mutagenicity of plant flavonoids: Structural requirements for mutagenic activity in Salmonella Typhimurium. Mutat. Res. 54: 297-309. https://doi.org/10.1016/0165-1161(78)90020-1
  20. Mallet, A. K., I. R. Rowland, C. A. Bearne, J. C. Flynn, B. T. Fehilly, Y. S. Udeen, and M. J. G. Farthing. 1988. Effect of dietary supplements of apple pectin, wheat bran or fat on the enzyme activity of the human fecal flora. Microb. Ecol. Health Dis. 1: 23-39. https://doi.org/10.3109/08910608809140175
  21. Matsumoto, H. 1980. In E. C. Miller, J. A. Miller, I. Hirono, T. Sugimura, and S. Takayama (eds.). Naturally Occurring Carcinogens-mutagens and Modulators of Carcinogenesis, pp. 67-77. Univ. Park Press, Baltimore, MD.
  22. Mykkanen, H., K. Laiho, and S. Salminen. 1998. Variations in fecal bacterial enzyme activities and associations with bowel function and diet in elderly subjects. J. Appl. Microbiol. 85: 37-41. https://doi.org/10.1046/j.1365-2672.1998.00454.x
  23. Nagao, M., Y. Takahashi, H. Yamanaka, and T. Sugimura. 1979. Mutagens in coffee and tea. Mutat. Res. 68: 101-106. https://doi.org/10.1016/0165-1218(79)90137-X
  24. Reddy, B. S., D. Hanson, S. Manar, L. Mathews, M. Sbaschnig, C. Sharma, and B. Simi. 1980. Effect of high fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J. Nutr. 110: 1880-1887.
  25. Tamura, G., C. Gold, A. Feerro-Luzzi, and B. Ames. 1980. Fecalase: A model for activation of dietary glycosides to mutagens by intestinal flora. Proc. Natl. Acad. Sci. USA. 77: 4961-4965. https://doi.org/10.1073/pnas.77.8.4961
  26. Trinh, H. T., E. H. Joh, H. Y. Kwak, N. J. Baek, and D. H. Kim. 2010. Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice. Acta Pharmacol. Sin. 31: 718-724. https://doi.org/10.1038/aps.2010.42
  27. Wakabayashi, C., H. Hasegawa, J. Murata, and I. Saiki. 1998. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Oncol. Res. 9: 411-417.
  28. Yim, J. S., Y. S. Kim, S. K. Moon, K. H. Cho, H. S. Bae, J. J. Kim, et al. 2004. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol. Pharm. Bull. 27: 1580-1583. https://doi.org/10.1248/bpb.27.1580

Cited by

  1. Role of intestinal microflora in xenobiotic‐induced toxicity vol.57, pp.1, 2012, https://doi.org/10.1002/mnfr.201200461
  2. The effect of gut microbiota on drug metabolism vol.9, pp.10, 2012, https://doi.org/10.1517/17425255.2013.807798
  3. Doenjang, a Fermented Korean Soybean Paste, Inhibits Lipopolysaccharide Production of Gut Microbiota in Mice vol.17, pp.1, 2014, https://doi.org/10.1089/jmf.2013.3073
  4. A New Approach to Produce Resveratrol by Enzymatic Bioconversion vol.26, pp.8, 2016, https://doi.org/10.4014/jmb.1512.12084
  5. How to Determine the Role of the Microbiome in Drug Disposition vol.46, pp.11, 2012, https://doi.org/10.1124/dmd.118.083402
  6. Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions vol.71, pp.2, 2019, https://doi.org/10.1124/pr.118.015768
  7. Ophiopogon Polysaccharide Promotes the In Vitro Metabolism of Ophiopogonins by Human Gut Microbiota vol.24, pp.16, 2012, https://doi.org/10.3390/molecules24162886
  8. Glucuronides Hydrolysis by Intestinal Microbial β-Glucuronidases (GUS) Is Affected by Sampling, Enzyme Preparation, Buffer pH, and Species vol.13, pp.7, 2021, https://doi.org/10.3390/pharmaceutics13071043